Click on a star to see more details touch_app
Concepts for which Josh L Plassmeyer has direct influence:
Prominent publications by Josh L Plassmeyer
KOL-Index: 2 RATIONALE: Currently, adjuvant endocrine therapy often follows a "one-size-fits- all" approach, with most premenopausal women receiving tamoxifen, and most postmenopausal receiving aromatase inhibitor therapy. In current clinical practice, patients with invasive lobular carcinoma are treated no differently than patients with invasive ductal carcinoma based on the void of information specific ...
|Known for |
Definitive Surgery | 250 Injections | Premenopausal Women | Size Fits-